These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17366659)

  • 41. Appraisal of treatment for severe sepsis in intensive care units.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16888847
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of recombinant human activated protein C in severe sepsis in patient with a pericardial hemorrhagic collection after a recent cardiac surgery].
    Fournet X; Dubernet-Gaudiot P; Treilhaud M; Blanloeil Y
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):435-6. PubMed ID: 15826797
    [No Abstract]   [Full Text] [Related]  

  • 43. [Xigris--activated protein C].
    Tønnesen EK
    Ugeskr Laeger; 2004 Mar; 166(11):1002-4. PubMed ID: 15049235
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessing the use of activated protein C in the treatment of severe sepsis.
    Siegel JP
    N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563
    [No Abstract]   [Full Text] [Related]  

  • 45. The use of drotrecogin alfa recombinant activated protein C for severe sepsis in the critically burned patient: a new treatment approach.
    Weintraub J; Satterwhite T; Allo M
    Burns; 2006 Sep; 32(6):783-7. PubMed ID: 16879921
    [No Abstract]   [Full Text] [Related]  

  • 46. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drotrecogin alfa (activated) in South African private hospital ICUs.
    Hodgson RE; Williams PG; Foden AP; Grolman D
    S Afr Med J; 2003 Jul; 93(7):474-5. PubMed ID: 12939910
    [No Abstract]   [Full Text] [Related]  

  • 48. Thromboembolic complications of sepsis: what is the incidence and pathophysiological mechanisms involved?
    Holub M
    Thromb Haemost; 2008 May; 99(5):801-2. PubMed ID: 18449407
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness of drotrecogin alfa (activated) in clinical practice: a stitch in time.
    Doig G
    Crit Care Med; 2008 Jan; 36(1):332-3. PubMed ID: 18158441
    [No Abstract]   [Full Text] [Related]  

  • 50. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of recombinant human activated protein C in patients with severe sepsis: a French retrospective multicentre study.
    Muller L; Jaber S; Raillard A; Lefrant JY
    Intensive Care Med; 2008 May; 34(5):977-9. PubMed ID: 18214426
    [No Abstract]   [Full Text] [Related]  

  • 52. Drotrecogin alfa: too early to give it early.
    Smith B
    Emerg Med Australas; 2005 Apr; 17(2):179-80. PubMed ID: 15796737
    [No Abstract]   [Full Text] [Related]  

  • 53. Vibrio vulnificus sepsis successfully treated with antibiotics, surgical debridement, and recombinant human activated protein C.
    Anand RG; Lopez FA; deBoisblanc B
    J La State Med Soc; 2004; 156(3):130-3; quiz 133. PubMed ID: 15233383
    [No Abstract]   [Full Text] [Related]  

  • 54. Sepsis and septic shock: inching forwards.
    Cohen J
    Clin Med (Lond); 2009 Jun; 9(3):256-7. PubMed ID: 19634390
    [No Abstract]   [Full Text] [Related]  

  • 55. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis].
    Bartelink AK
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):352-4. PubMed ID: 16523795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kigris. FDA approves first biologic for sepsis.
    Nursing; 2002 Feb; 32(2):18. PubMed ID: 11924158
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of patients with severe sepsis and septic shock: real-life lessons.
    Davidow JS; Brindley PG; Jacka MJ; Gibney RT
    CJEM; 2006 Jul; 8(4):244-5. PubMed ID: 17324301
    [No Abstract]   [Full Text] [Related]  

  • 58. Beyond sepsis: activated protein C and heat stroke.
    Brueckmann M; Hoffmann U; Borggrefe M
    Crit Care Med; 2006 Jul; 34(7):2020-1. PubMed ID: 16801873
    [No Abstract]   [Full Text] [Related]  

  • 59. Forums for expressing concerns.
    Aberegg SK
    Crit Care Med; 2005 Jun; 33(6):1467; author reply 1467-8. PubMed ID: 15942401
    [No Abstract]   [Full Text] [Related]  

  • 60. What you need to know about sepsis.
    Wood S; Lavieri MC; Durkin T
    Nursing; 2007 Mar; 37(3):46-51; quiz 52. PubMed ID: 17546784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.